Blood Cancer Journal Contents: 31 May 2022

The latest content from Blood Cancer Journal: 31 May 2022

High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions Patrick Hagen, Jiwang Zhang & Kevin Barton Review Article | 30 May 2022 | Article number: 83 |  doi: 10.1038/s41408-022-00679-5

Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib Alexander E. Perl, Naoko Hosono [...] Jessica K. Altman Article | 30 May 2022 | Article number: 84 |  doi: 10.1038/s41408-022-00677-7

Structural variants shape the genomic landscape and clinical outcome of multiple myeloma Cody Ashby, Eileen M. Boyle [...] Gareth J. Morgan Article | 30 May 2022 | Article number: 85 |  doi: 10.1038/s41408-022-00673-x

Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study Christopher Staffi Buradagunta, Zhuping Garacci [...] Jing Dong Correspondence | 25 May 2022 | Article number: 82 |  doi: 10.1038/s41408-022-00681-x

Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia Takaaki Konuma, Shohei Mizuno [...] Masamitsu Yanada Article | 25 May 2022 | Article number: 81 |  doi: 10.1038/s41408-022-00678-6

Pirtobrutinib inhibits wild-type and mutant Bruton's tyrosine kinase-mediated signaling in chronic lymphocytic leukemia Burcu Aslan, Gorkem Kismali [...] Varsha Gandhi Article | 20 May 2022 | Article number: 80 |  doi: 10.1038/s41408-022-00675-9

Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study Paloma García-Martín, Ana Moñiz Díez [...] Juan Sainz Correspondence | 17 May 2022 | Article number: 79 |  doi: 10.1038/s41408-022-00676-8

PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts Sanjal H. Desai, Levi Pederson [...] Grzegorz S. Nowakowski Article | 03 May 2022 | Article number: 78 |  doi: 10.1038/s41408-022-00649-x

Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML Musa Yilmaz, Hagop Kantarjian [...] Naval Daver Article | 02 May 2022 | Article number: 77 |  doi: 10.1038/s41408-022-00670-0

Journal Info Submit Manuscript RSS Feed

This email has been sent to ignoble.experiment@arconati.us by Blood Cancer Journal.

Unsubscribe Manage Alerts Privacy policy Contact us

Springer Nature Limited is a company registered in England and Wales under Company Number 785998 with its registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom

Nature is part of Springer Nature. © 2022 Springer Nature Limited. All rights reserved.